1-ethyl-4-oxo-6-(trifluoromethyl)-1,4-dihydroquinoline-3-carboxylic acid | 218964-99-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 英文名称: 1-ethyl-4-oxo-6-(trifluoromethyl)-1,4-dihydroquinoline-3-carboxylic acid
• 英文别名: 1-ethyl-4-oxo-6-(trifluoromethyl)quinoline-3-carboxylic acid
• CAS: 218964-99-9
• 化学式: C₁₃H₁₀F₃NO₃
• 分子量: 285.223
• InChiKey: GJWNJAAWTWYLPO-UHFFFAOYSA-N

物化性质

• 熔点：
  224 °C
• 沸点：
  381.0±42.0 °C(Predicted)
• 密度：
  1.437±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.9
• 重原子数：
  20
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.23
• 拓扑面积：
  57.6
• 氢给体数：
  1
• 氢受体数：
  7

反应信息

• 作为反应物：
  描述：

  1-ethyl-4-oxo-6-(trifluoromethyl)-1,4-dihydroquinoline-3-carboxylic acid 在 三乙胺 作用下， 以 二氯甲烷 为溶剂， 生成 1-ethyl-4-oxo-N-(2-phenylethyl)-6-(trifluoromethyl)quinoline-3-carboxamide
  参考文献：
  名称：

  Synthesis and evaluation of a novel series of phosphodiesterase IV inhibitors. A potential treatment for asthma

  摘要：

  The synthesis and pharmacological profile of a novel series of potent and selective phosphodiesterase type IV (PDE IV) inhibitors is described. (C) 1998 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(98)00490-9
• 作为产物：
  描述：

  对三氟甲基苯胺 在 lithium hydroxide 、 sodium hydride 作用下， 以 四氢呋喃 、 N,N-二甲基甲酰胺 为溶剂， 反应 3.0h， 生成 1-ethyl-4-oxo-6-(trifluoromethyl)-1,4-dihydroquinoline-3-carboxylic acid
  参考文献：
  名称：

  Synthesis and evaluation of a novel series of phosphodiesterase IV inhibitors. A potential treatment for asthma

  摘要：

  The synthesis and pharmacological profile of a novel series of potent and selective phosphodiesterase type IV (PDE IV) inhibitors is described. (C) 1998 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(98)00490-9

文献信息

• A Small-Molecule Inhibitor of Nipah Virus Envelope Protein-Mediated Membrane Fusion
  作者：Sabine Niedermeier、Katrin Singethan、Sebastian G. Rohrer、Magnus Matz、Markus Kossner、Sandra Diederich、Andrea Maisner、Jens Schmitz、Georg Hiltensperger、Knut Baumann、Ulrike Holzgrabe、Jürgen Schneider-Schaulies

  DOI：10.1021/jm900411s

  日期：2009.7.23

  Nipah virus (NiV), a highly pathogenic paramyxovirus. causes respiratory disease in pigs and severe febrile encephalitis in humans with high mortality rates. On the basis of the structural similarity of viral fusion (F) proteins within the family Paramyxoviridae, we designed and tested 18 quinolone derivatives in a NiV and measles virus (MV) envelope protein-based fusion assay beside evaluation of cytotoxicity. We found five compounds successfully inhibiting NiV envelope protein-induced cell fusion. The most active molecules (19 and 20), which also inhibit the syncytium formation induced by infectious NiV and show a low cytotoxicity in Vero cells, represent a promising lead quinolone-type compound structure. Molecular modeling indicated that compound 19 fits well into a particular protein cavity present on the NiV F protein that is important for the fusion process.
• Synthesis and evaluation of a novel series of phosphodiesterase IV inhibitors. A potential treatment for asthma
  作者：Steven C. Beasley、Nicola Cooper、Lewis Gowers、Joanna P. Gregory、Alan F Haughan、Paul G. Hellewell、David Macari、Jadwiga Miotla、John G. Montana、Trevor Morgan、Robert Naylor、Karen A. Runcie、Bishwa Tuladhar、Julie B.H. Warneck

  DOI：10.1016/s0960-894x(98)00490-9

  日期：1998.10

  The synthesis and pharmacological profile of a novel series of potent and selective phosphodiesterase type IV (PDE IV) inhibitors is described. (C) 1998 Elsevier Science Ltd. All rights reserved.